Publications by authors named "Tracey Roberts"

Claim this Profile
A
Automatic Population of the Case Report Forms for an International Multifactorial Adaptive Platform Trial Amid the COVID-19 Pandemic.
Andrew J King, Lisa Higgins, Carly Au, Salim Malakouti, Edvin Music, Tracey Roberts

AMIA Jt Summits Transl Sci Proc· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of preoperative oral nutrition supplementation on outcomes in patients undergoing gastrointestinal surgery for cancer in low- and middle-income countries: a systematic review and meta-analysis.
Stephen R Knight, Ahmad U Qureshi, Thomas M Drake, Marie Carmela M Lapitan, Mayaba Maimbo, Tracey E Roberts

Sci Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance Evaluation of Nasal Prong Interface for CPAP Delivery on a Critical Care Ventilator: A Bench Experiment.
Natalie Napolitano, Tracey Roberts, Amanda J Nickel, Joseph McDonough, Haorui Sun

Respir Care· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial.
John F Kokai-Kun, Tracey Roberts, Olivia Coughlin, Chenxiong Le, Heidi Whalen

Lancet Infect Dis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.
John F Kokai-Kun, Tracey Roberts, Olivia Coughlin, Eric Sicard, Marianne Rufiange

Antimicrob Agents Chemother· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and Pharmacokinetics of SYN-004, an Orally Administered β-Lactamase for the Prevention of Clostridium difficile-Associated Disease and Antibiotic-Associated Diarrhea, in Two Phase 1 Studies.
Tracey Roberts, John F Kokai-Kun, Olivia Coughlin, Barbara Valero Lopez, Heidi Whalen

Clin Drug Investig· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripatetic intravenous service for metabolic bone disease: case study in patient centred-care for new NHS.
Michael Davie, Paula Jeffreson, Teresa Jones, Tracey Roberts, Femi Adekunle

Curr Med Res Opin· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis